These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9271779)

  • 1. Monitoring serum concentrations of clomipramine and metabolites: fluorescence polarization immunoassay versus high performance liquid chromatography.
    Banger M; Hermes B; Härtter S; Hiemke C
    Pharmacopsychiatry; 1997 Jul; 30(4):128-32. PubMed ID: 9271779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring tricyclic antidepressant concentrations in serum by fluorescence polarization immunoassay compared with gas chromatography and HPLC.
    Rao ML; Staberock U; Baumann P; Hiemke C; Deister A; Cuendet C; Amey M; Härtter S; Kraemer M
    Clin Chem; 1994 Jun; 40(6):929-33. PubMed ID: 8087988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.
    Szegedi A; Wetzel H; Leal M; Härtter S; Hiemke C
    J Clin Psychiatry; 1996 Jun; 57(6):257-64. PubMed ID: 8666564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic drug monitoring in depression--new perspectives].
    Radziwoń-Zaleska M; Matsumoto H; Skalski M; Dziklińska A; Androsiuk W; Wakarow A; Wilkowska J; Matoszko D; Kuczyńska J; Goluch J
    Psychiatr Pol; 2002; 36(6 Suppl):71-80. PubMed ID: 12647424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of high-performance liquid chromatography and fluorescence polarization immunoassay for therapeutic drug monitoring of tricyclic antidepressants.
    Hackett LP; Dusci LJ; Ilett KF
    Ther Drug Monit; 1998 Feb; 20(1):30-4. PubMed ID: 9485551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of HPLC with silica-phase and reversed-phase eluents for the determination of clomipramine and demethylated and 8-hydroxylated metabolites.
    Coudoré F; Hourcade F; Molinier-Manoukian C; Eschalier A; Lavarenne J
    J Anal Toxicol; 1996; 20(2):101-5. PubMed ID: 8868400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group.
    Nielsen KK; Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1992; 43(4):405-11. PubMed ID: 1451721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
    Rao ML; Deister A; Laux G; Staberock U; Höflich G; Möller HJ
    Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are gender differences important for the clinical effects of antidepressants?
    Hildebrandt MG; Steyerberg EW; Stage KB; Passchier J; Kragh-Soerensen P;
    Am J Psychiatry; 2003 Sep; 160(9):1643-50. PubMed ID: 12944340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma steady-state concentrations of hydroxylated metabolites of clomipramine.
    Linnoila M; Insel T; Kilts C; Potter WZ; Murphy DL
    Clin Pharmacol Ther; 1982 Aug; 32(2):208-11. PubMed ID: 7094507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine.
    Dasgupta A; Wells A; Datta P
    Ther Drug Monit; 2007 Feb; 29(1):134-9. PubMed ID: 17333576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Danish University Antidepressant Group (DUAG).
    Clin Pharmacol Ther; 1999 Aug; 66(2):152-65. PubMed ID: 10460069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated determination of clomipramine and its major metabolites in human and rat serum by high-performance liquid chromatography with on-line column-switching.
    Weigmann H; Härtter S; Hiemke C
    J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):227-33. PubMed ID: 9686892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma concentrations of clomipramine and its desmethyl metabolite in man. Methodologic limits].
    Piollet I; Goyot C; Paire M; Touzery A; Eschalier A; Dehennin L; Grenier J; Lavarenne J; Zarifian E
    Encephale; 1988; 14(4):287-92. PubMed ID: 3197636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved clean-up procedure for the high-performance liquid chromatographic assay of clomipramine and its demethylated metabolite in human plasma.
    Altieri I; Pichini S; Pacifici R; Zuccaro P
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):416-7. PubMed ID: 7581922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.
    Brown JT; Schneiderhan M; Eum S; Bishop JR
    Pharmacogenomics; 2017 May; 18(7):601-605. PubMed ID: 28470111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment.
    Marcourakis T; Bernik MA; Lotufo Neto F; Gedanke Shavitt R; Gorenstein C
    Int Clin Psychopharmacol; 2015 Jan; 30(1):43-8. PubMed ID: 25279584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomipramine augmentation in treatment-resistant depression.
    Amsterdam JD; García-España F; Rosenzweig M
    Depress Anxiety; 1997; 5(2):84-90. PubMed ID: 9262938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients.
    Yokono A; Morita S; Someya T; Hirokane G; Okawa M; Shimoda K
    J Clin Psychopharmacol; 2001 Dec; 21(6):549-55. PubMed ID: 11763000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fluorescence polarization immunoassay with liquid chromatography for quantification of procainamide and N-acetylprocainamide in urine.
    Tisdale JE; Padhi ID; Ware JA; Svensson CK
    Ther Drug Monit; 1996 Dec; 18(6):693-7. PubMed ID: 8946667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.